Stuart H. Ralston

1984–2025 年に発表

別表記
Stuart H Ralston
183
論文数
29,015
被引用数
108
h 指数
180
i10 指数

被引用数

Stuart H. Ralston の年別被引用数1974 年: 被引用 1 件1985 年: 被引用 6 件1986 年: 被引用 3 件1987 年: 被引用 3 件1988 年: 被引用 3 件1989 年: 被引用 5 件1990 年: 被引用 3 件1991 年: 被引用 12 件1992 年: 被引用 15 件1993 年: 被引用 14 件1994 年: 被引用 11 件1995 年: 被引用 24 件1996 年: 被引用 46 件1997 年: 被引用 50 件1998 年: 被引用 80 件1999 年: 被引用 111 件2000 年: 被引用 138 件2001 年: 被引用 201 件2002 年: 被引用 190 件2003 年: 被引用 202 件2004 年: 被引用 169 件2005 年: 被引用 201 件2006 年: 被引用 204 件2007 年: 被引用 162 件2008 年: 被引用 210 件2009 年: 被引用 192 件2010 年: 被引用 244 件2011 年: 被引用 174 件2012 年: 被引用 185 件2013 年: 被引用 171 件2014 年: 被引用 149 件2015 年: 被引用 155 件2016 年: 被引用 182 件2017 年: 被引用 131 件2018 年: 被引用 157 件2019 年: 被引用 589 件2020 年: 被引用 646 件2021 年: 被引用 580 件2022 年: 被引用 539 件2023 年: 被引用 370 件2024 年: 被引用 612 件2025 年: 被引用 231 件2026 年: 被引用 7 件1975〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,115 件、この内訳の 22.3%イギリス: 引用元論文 1,147 件、この内訳の 12.1%中国: 引用元論文 772 件、この内訳の 8.1%ドイツ: 引用元論文 461 件、この内訳の 4.9%イタリア: 引用元論文 419 件、この内訳の 4.4%オーストラリア: 引用元論文 380 件、この内訳の 4%カナダ: 引用元論文 365 件、この内訳の 3.9%オランダ: 引用元論文 348 件、この内訳の 3.7%日本: 引用元論文 305 件、この内訳の 3.2%フランス: 引用元論文 295 件、この内訳の 3.1%スペイン: 引用元論文 192 件、この内訳の 2%スイス: 引用元論文 187 件、この内訳の 2%
0%22.3%その他 26.3%

分野

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology25.7%
  • Immunology and Microbiology2.1%
  • Neuroscience1.8%
  • Engineering1.1%
  • Nursing0.6%
  • その他2.9%

トピック

  • Bone health and osteoporosis research7.9%
  • Bone health and treatments6.5%
  • Bone Metabolism and Diseases6.5%
  • Gout, Hyperuricemia, Uric Acid2.5%
  • Osteoarthritis Treatment and Mechanisms2.1%
  • Bone and Joint Diseases2%
  • その他72.5%

共著者

全論文

検索で開く
  1. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurent F. Thomas, Margo Tuerlings, John Loughlin, Nigel Arden, Fraser Birrell, Andrew Carr, Panos Deloukas, Michael Doherty, Andrew W. McCaskie, William Ollier, Ashok Rai, Stuart H. Ralston, Tim D. Spector, Gillian A. Wallis, Amy E. Martinsen, Cristen J. Willer, Egil A. Fors, Ingunn Mundal, Knut Hagen, Kristian Bernhard Nilsen, Marie Udnesseter Lie, Sigrid Børte, Ben Brumpton, Jonas B. Nielsen, Lars G. Fritsche, Wei Zhou, Ingrid Heuch, Kjersti Storheim, Evangelos Tyrpenou, A. Koukakis, Dimitrios Chytas, Dimitrios Stergios Evangelopoulos, Chronopoulos Efstathios, Spiros G. Pneumaticos, Vasileios S. Nikolaou, Κonstantinos Ν. Malizos, Lydia Anastasopoulou, Gonçalo R. Abecasis, Aris Baras, Michael Cantor, Giovanni Coppola, Andrew Deubler, Aris N. Economides, Luca A. Lotta, John D. Overton, Jeffrey G. Reid, Alan R. Shuldiner, Katia Karalis, Katherine Siminovitch, Christina Beechert, Caitlin Forsythe, Erin D. Fuller, Zhenhua Gu, Michael Lattari, Alexander Lopez, Thomas D. Schleicher, Maria Sotiropoulos Padilla, Louis Widom, Sarah E. Wolf, Manasi Pradhan, Kia Manoochehri, Xiaodong Bai, Suganthi Balasubramanian, Boris Boutkov, Gisu Eom, Lukas Habegger, Alicia Hawes, Olga Krasheninina, Rouel Lanche, Adam J. Mansfield ほか 55 名 - Cell 2021 被引用: 467

  2. Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

    著者: , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2020 被引用: 352

  3. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Douglas Rooke, John Thomson, M.A. Warren, Kirsty Wetherall, Robbie S. Wilson, C.P. Hall, A Maseri, H. A. Bird, Gordon Murray, James W. Dear, Mark C. Petrie, Michael P. MacDonald, Pardeep S. Jhund, Elizabeth A. Connolly, David J. Murphy, Narinder Paul, A G Olsson, P.T. Koskinen, A. Fuat, Alexis Foster, Wendy Saywood, R.J. Barr, Lewis McConnachie, Louis F. Wilson, L. Larsen Rasmussen, A.R. McGinnis, H Birrell, M. Keiller, I.S. Bremner, Gareth Forbes, Jennifer Dumbleton, Jonathan Rhodes, Theodore Waller - The Lancet 2020 被引用: 342

  4. Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Karasik, Nathalie van der Velde, M. Arfan Ikram, Babette S. Zemel, Yanhua Zhou, Christian J. Carlsson, Ching‐Ti Liu, Fiona E. McGuigan, Cindy G. Boer, Klaus Bønnelykke, Stuart H. Ralston, John A. Robbins, John P. Walsh, M. Carola Zillikens, Claudia Langenberg, Ruifang Li‐Gao, Frances M. K. Williams, Tamara B. Harris, Kristina Åkesson, Rebecca D. Jackson, Gunnar Sigurðsson, Martin den Heijer, Bram C. J. van der Eerden, Jeroen van de Peppel, Timothy D. Spector, Craig E. Pennell, Bernardo Lessa Horta, Janine F. Felix, Jing Hua Zhao, Scott G. Wilson, Renée de Mutsert, Hans Bisgaard, Unnur Styrkársdóttir, Vincent W. V. Jaddoe, Eric Orwoll, Timo A. Lakka, Robert A. Scott, Struan F.A. Grant, Mattias Lorentzon, Cornelia M. van Duijn, James F. Wilson, Kari Stefansson, Bruce M. Psaty, Douglas P. Kiel, Claes Ohlsson, Evangelia Ntzani, André J. van Wijnen, Vincenzo Forgetta, Mohsen Ghanbari, John G. Logan, Graham R. Williams, J. H. Duncan Bassett, Peter I. Croucher, Εvangelos Εvangelou, André G. Uitterlinden, Cheryl L. Ackert‐Bicknell, Jonathan H. Tobias, David M. Evans, Fernando Rivadeneira - The American Journal of Human Genetics 2018 被引用: 361

  5. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sagar N. Doshi, Moira Dryburgh, Michael Eddleston, Jim Finlayson, Ahmet Fuat, Jacqueline Furnace, JW Kerr Grieve, Greg Guthrie, Sharon Ham, Emma Isaard, Claudine G. Jennings, Richard J. Johnson, Claire Kerr, Sohail Khan, Kailash Krishnan, Susan Long, A. S. Mackintosh, Mary Joan MacLeod, Terry McCormack, Paul McEleny, Monique Morar, Adnan Nadir, David E. Newby, Colin J. Petrie, David Preiss, Stuart H. Ralston, Marc Randall, Helen Routledge, Saad Shakir, Raj Kumar Sharma, Bridget Shepherd, Don Sims, Gordon Snedden, Jasper Trevelyan, Christopher J. Weir, Robin A.P. Weir, Kirsty Wetherall, Robbie S. Wilson, Adam Wilson, Kris Zutis - The Lancet 2022 被引用: 157

  6. Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS

    著者: , , , , , , , , , - Bone 2017 被引用: 491

  7. Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2021 被引用: 145

  8. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louise A. Donnelly, Lynette D. Fairbanks, Martin Aringer, Paul McKeigue, Stuart H. Ralston, Andrew D. Morris, Pavao Rudan, Nicholas D. Hastie, Harry Campbell, Alan F. Wright - Nature Genetics 2008 被引用: 806

  9. Role of the Microbiome in Regulating Bone Metabolism and Susceptibility to Osteoporosis

    著者: , , , , , , , , , , , , , , , , , , , - Calcified Tissue International 2021 被引用: 54

  10. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Markus M. Nöthen, Martin Aringer, Annegret Kuhn, Kirsten Lüthke, L. Unger, Annette Bley, Alice Lorenzi, John D. Isaacs, Dimitra Alexopoulou, Karsten Conrad, Andreas Dahl, Axel Roers, Marta E. Alarcón‐Riquelme, Andrew P. Jackson, Min Ae Lee-Kirsch - Journal of Clinical Investigation 2014 被引用: 222

  11. A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2009 被引用: 1,426

  12. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society

    著者: , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2019 被引用: 109

  13. Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - BMC Medical Genetics 2006 被引用: 312

  14. Bisphosphonates for the Prevention of Fractures in Osteogenesis Imperfecta: Meta-Analysis of Placebo-Controlled Trials

    著者: , , , - Journal of Bone and Mineral Research 2014 被引用: 131

  15. Management of Osteogenesis Imperfecta

    著者: , - Frontiers in Endocrinology 2020 被引用: 125

  16. Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - RMD Open 2021 被引用: 72

  17. Nitric oxide and bone

    著者: , - Immunology 2001 被引用: 518

  18. Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis

    著者: , , , , - Lara D. Veeken 2014 被引用: 159

  19. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Osteoporosis International 2012 被引用: 336

  20. Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Calcified Tissue International 2019 被引用: 160

  21. Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

    著者: , , , , , , , , , , , , , , , , - RMD Open 2023 被引用: 36

  22. A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease

    著者: , , , , , - Rheumatology International 2021 被引用: 29

  23. Presentation and management of osteoporosis presenting in association with pregnancy or lactation

    著者: , - Osteoporosis International 2015 被引用: 262

  24. ER Stress-Mediated Apoptosis in a New Mouse Model of Osteogenesis imperfecta

    著者: , , , , , , , , , , , , - PLoS Genetics 2008 被引用: 166